Filing Details
- Accession Number:
- 0001567619-19-013838
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-06-21 16:59:31
- Reporting Period:
- 2019-06-21
- Accepted Time:
- 2019-06-21 16:59:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1623526 | Stoke Therapeutics Inc. | STOK | () | E9 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1593440 | Apple Tree Partners Iv, L.p. | C/O Stoke Therapeutics, Inc. 45 Wiggins Avenue Bedford MA 01730 | No | No | Yes | No | |
| 1593453 | Atp Iii Gp, Ltd. | C/O Stoke Therapeutics, Inc. 45 Wiggins Avenue Bedford MA 01730 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-06-21 | 4,980,168 | $0.00 | 4,980,168 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2019-06-21 | 7,617,746 | $0.00 | 12,597,914 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2019-06-21 | 2,799,910 | $0.00 | 15,397,824 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2019-06-21 | 1,388,889 | $18.00 | 16,786,713 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Direct | |
| No | 4 | C | Direct | |
| No | 4 | C | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series A Convertible Preferred Stock | Disposition | 2019-06-21 | 4,980,168 | $0.00 | 4,980,168 | $0.00 |
| Common Stock | Series A-2 Convertible Preferred Stock | Disposition | 2019-06-21 | 7,617,746 | $0.00 | 7,617,746 | $0.00 |
| Common Stock | Series B Convertible Preferred Stock | Disposition | 2019-06-21 | 2,799,910 | $0.00 | 2,799,910 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct |
Footnotes
- The shares of Series A Convertible Preferred Stock, Series A-2 Convertible Preferred Stock, Series B Convertible Preferred Stock automatically converted into the Issuer's Common Stock on a 1-for-1 basis upon the closing of the Issuer's initial public offering on June 21, 2019.
- Apple Tree Partners IV, L.P. ("ATP IV"). ATP III GP, Ltd. ("ATP III"), is the sole general partner of ATP IV. Seth Harrison, a director of Issuer, is the sole director of ATP III and may be deemed to have sole voting and dispositive power over the shares held by ATP IV. Dr. Harrison disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein.
Billionaire Hedge Funds
